aluates Reports

$ 0.0

Automative

Global Antibody Drug CDMO Service Market Research Report 2026

Published Date: 2026-02-09

Report Code: QYRE-Auto-9O18473

Global Antibody Drug CDMO Service Market Research Report 2024

BUY CHAPTERS

Global Antibody Drug CDMO Service Market Research Report 2026

Code: QYRE-Auto-9O18473

Report

2026-02-09

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abzena

AGC Biologics

Axplora

Batavia Biosciences

Chemexpress

Fujifilm

GTP Bioways

HALIX

Mycenax

Wuxi Biologics

ProBio

Samsung Biologics

Sigma-aldrich

Antibody Drug CDMO Service Market

The global Antibody Drug CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Antibody Drug CDMO Service (Contract Development and Manufacturing Organization) refers to a business model that provides full-chain services from R&D to production for antibody drugs. This service model covers all stages of antibody drug R&D, including preclinical research, clinical research and commercial production, and aims to help pharmaceutical companies accelerate the R&D process of antibody drugs, improve production efficiency and reduce production costs through professional technical capabilities and production facilities.

The North American market for Antibody Drug CDMO Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Antibody Drug CDMO Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Antibody Drug CDMO Service in Antibody Drug Conjugates is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Antibody Drug CDMO Service include Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix, MYCENAX, WuXi Biologics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Antibody Drug CDMO Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antibody Drug CDMO Service. The Antibody Drug CDMO Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Antibody Drug CDMO Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Antibody Drug CDMO Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Antibody Drug CDMO Service Market Report

Report Metric	Details
Report Name	Antibody Drug CDMO Service Market
Segment by Type	Customized Service Lab-based Service Others
Segment by Application	Antibody Drug Conjugates Monoclonal Antibodies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix, MYCENAX, WuXi Biologics, ProBio, Samsung Biologics, Sigma-Aldrich
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Antibody Drug CDMO Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody Drug CDMO Service Market report?

Ans: The main players in the Antibody Drug CDMO Service Market are Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix, MYCENAX, WuXi Biologics, ProBio, Samsung Biologics, Sigma-Aldrich

What are the Application segmentation covered in the Antibody Drug CDMO Service Market report?

Ans: The Applications covered in the Antibody Drug CDMO Service Market report are Antibody Drug Conjugates, Monoclonal Antibodies, Others

What are the Type segmentation covered in the Antibody Drug CDMO Service Market report?

Ans: The Types covered in the Antibody Drug CDMO Service Market report are Customized Service, Lab-based Service, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Drug CDMO Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Customized Service

1.2.3 Lab-based Service

1.2.4 Others

1.3 Market by Application

1.3.1 Global Antibody Drug CDMO Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Antibody Drug Conjugates

1.3.3 Monoclonal Antibodies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Drug CDMO Service Market Perspective (2021–2032)

2.2 Global Antibody Drug CDMO Service Growth Trends by Region

2.2.1 Global Antibody Drug CDMO Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Antibody Drug CDMO Service Historic Market Size by Region (2021–2026)

2.2.3 Antibody Drug CDMO Service Forecasted Market Size by Region (2027–2032)

2.3 Antibody Drug CDMO Service Market Dynamics

2.3.1 Antibody Drug CDMO Service Industry Trends

2.3.2 Antibody Drug CDMO Service Market Drivers

2.3.3 Antibody Drug CDMO Service Market Challenges

2.3.4 Antibody Drug CDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Drug CDMO Service Players by Revenue

3.1.1 Global Top Antibody Drug CDMO Service Players by Revenue (2021–2026)

3.1.2 Global Antibody Drug CDMO Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Antibody Drug CDMO Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Antibody Drug CDMO Service Revenue

3.4 Global Antibody Drug CDMO Service Market Concentration Ratio

3.4.1 Global Antibody Drug CDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug CDMO Service Revenue in 2025

3.5 Global Key Players of Antibody Drug CDMO Service Head Offices and Areas Served

3.6 Global Key Players of Antibody Drug CDMO Service, Products and Applications

3.7 Global Key Players of Antibody Drug CDMO Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Antibody Drug CDMO Service Breakdown Data by Type

4.1 Global Antibody Drug CDMO Service Historic Market Size by Type (2021–2026)

4.2 Global Antibody Drug CDMO Service Forecasted Market Size by Type (2027–2032)

5 Antibody Drug CDMO Service Breakdown Data by Application

5.1 Global Antibody Drug CDMO Service Historic Market Size by Application (2021–2026)

5.2 Global Antibody Drug CDMO Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Antibody Drug CDMO Service Market Size (2021–2032)

6.2 North America Antibody Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Antibody Drug CDMO Service Market Size by Country (2021–2026)

6.4 North America Antibody Drug CDMO Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Drug CDMO Service Market Size (2021–2032)

7.2 Europe Antibody Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Antibody Drug CDMO Service Market Size by Country (2021–2026)

7.4 Europe Antibody Drug CDMO Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Antibody Drug CDMO Service Market Size (2021–2032)

8.2 Asia-Pacific Antibody Drug CDMO Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Antibody Drug CDMO Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Antibody Drug CDMO Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Antibody Drug CDMO Service Market Size (2021–2032)

9.2 Latin America Antibody Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Antibody Drug CDMO Service Market Size by Country (2021–2026)

9.4 Latin America Antibody Drug CDMO Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Drug CDMO Service Market Size (2021–2032)

10.2 Middle East & Africa Antibody Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abzena

11.1.1 Abzena Company Details

11.1.2 Abzena Business Overview

11.1.3 Abzena Antibody Drug CDMO Service Introduction

11.1.4 Abzena Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.1.5 Abzena Recent Development

11.2 AGC Biologics

11.2.1 AGC Biologics Company Details

11.2.2 AGC Biologics Business Overview

11.2.3 AGC Biologics Antibody Drug CDMO Service Introduction

11.2.4 AGC Biologics Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.2.5 AGC Biologics Recent Development

11.3 Axplora

11.3.1 Axplora Company Details

11.3.2 Axplora Business Overview

11.3.3 Axplora Antibody Drug CDMO Service Introduction

11.3.4 Axplora Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.3.5 Axplora Recent Development

11.4 Batavia Biosciences

11.4.1 Batavia Biosciences Company Details

11.4.2 Batavia Biosciences Business Overview

11.4.3 Batavia Biosciences Antibody Drug CDMO Service Introduction

11.4.4 Batavia Biosciences Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.4.5 Batavia Biosciences Recent Development

11.5 ChemExpress

11.5.1 ChemExpress Company Details

11.5.2 ChemExpress Business Overview

11.5.3 ChemExpress Antibody Drug CDMO Service Introduction

11.5.4 ChemExpress Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.5.5 ChemExpress Recent Development

11.6 FUJIFILM

11.6.1 FUJIFILM Company Details

11.6.2 FUJIFILM Business Overview

11.6.3 FUJIFILM Antibody Drug CDMO Service Introduction

11.6.4 FUJIFILM Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.6.5 FUJIFILM Recent Development

11.7 GTP Bioways

11.7.1 GTP Bioways Company Details

11.7.2 GTP Bioways Business Overview

11.7.3 GTP Bioways Antibody Drug CDMO Service Introduction

11.7.4 GTP Bioways Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.7.5 GTP Bioways Recent Development

11.8 Halix

11.8.1 Halix Company Details

11.8.2 Halix Business Overview

11.8.3 Halix Antibody Drug CDMO Service Introduction

11.8.4 Halix Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.8.5 Halix Recent Development

11.9 MYCENAX

11.9.1 MYCENAX Company Details

11.9.2 MYCENAX Business Overview

11.9.3 MYCENAX Antibody Drug CDMO Service Introduction

11.9.4 MYCENAX Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.9.5 MYCENAX Recent Development

11.10 WuXi Biologics

11.10.1 WuXi Biologics Company Details

11.10.2 WuXi Biologics Business Overview

11.10.3 WuXi Biologics Antibody Drug CDMO Service Introduction

11.10.4 WuXi Biologics Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.10.5 WuXi Biologics Recent Development

11.11 ProBio

11.11.1 ProBio Company Details

11.11.2 ProBio Business Overview

11.11.3 ProBio Antibody Drug CDMO Service Introduction

11.11.4 ProBio Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.11.5 ProBio Recent Development

11.12 Samsung Biologics

11.12.1 Samsung Biologics Company Details

11.12.2 Samsung Biologics Business Overview

11.12.3 Samsung Biologics Antibody Drug CDMO Service Introduction

11.12.4 Samsung Biologics Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.12.5 Samsung Biologics Recent Development

11.13 Sigma-Aldrich

11.13.1 Sigma-Aldrich Company Details

11.13.2 Sigma-Aldrich Business Overview

11.13.3 Sigma-Aldrich Antibody Drug CDMO Service Introduction

11.13.4 Sigma-Aldrich Revenue in Antibody Drug CDMO Service Business (2021–2026)

11.13.5 Sigma-Aldrich Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abzena

AGC Biologics

Axplora

Batavia Biosciences

Chemexpress

Fujifilm

GTP Bioways

HALIX

Mycenax

Wuxi Biologics

ProBio

Samsung Biologics

Sigma-aldrich

List of Tables

Table 1. Global Antibody Drug CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Customized Service

Table 3. Key Players of Lab-based Service

Table 4. Key Players of Others

Table 5. Global Antibody Drug CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Antibody Drug CDMO Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Antibody Drug CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 8. Global Antibody Drug CDMO Service Market Share by Region (2021–2026)

Table 9. Global Antibody Drug CDMO Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Antibody Drug CDMO Service Market Share by Region (2027–2032)

Table 11. Antibody Drug CDMO Service Market Trends

Table 12. Antibody Drug CDMO Service Market Drivers

Table 13. Antibody Drug CDMO Service Market Challenges

Table 14. Antibody Drug CDMO Service Market Restraints

Table 15. Global Antibody Drug CDMO Service Revenue by Players (US$ Million), 2021–2026

Table 16. Global Antibody Drug CDMO Service Market Share by Players (2021–2026)

Table 17. Global Top Antibody Drug CDMO Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antibody Drug CDMO Service Revenue, 2025

Table 18. Ranking of Global Top Antibody Drug CDMO Service Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Antibody Drug CDMO Service Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Antibody Drug CDMO Service, Headquarters and Area Served

Table 21. Global Key Players of Antibody Drug CDMO Service, Products and Applications

Table 22. Global Key Players of Antibody Drug CDMO Service, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Antibody Drug CDMO Service Market Size by Type (US$ Million), 2021–2026

Table 25. Global Antibody Drug CDMO Service Revenue Market Share by Type (2021–2026)

Table 26. Global Antibody Drug CDMO Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Antibody Drug CDMO Service Revenue Market Share by Type (2027–2032)

Table 28. Global Antibody Drug CDMO Service Market Size by Application (US$ Million), 2021–2026

Table 29. Global Antibody Drug CDMO Service Revenue Market Share by Application (2021–2026)

Table 30. Global Antibody Drug CDMO Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Antibody Drug CDMO Service Revenue Market Share by Application (2027–2032)

Table 32. North America Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Antibody Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 34. North America Antibody Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Antibody Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Antibody Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Antibody Drug CDMO Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Antibody Drug CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Antibody Drug CDMO Service Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Antibody Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Antibody Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Antibody Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Antibody Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 47. Abzena Company Details

Table 48. Abzena Business Overview

Table 49. Abzena Antibody Drug CDMO Service Product

Table 50. Abzena Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 51. Abzena Recent Development

Table 52. AGC Biologics Company Details

Table 53. AGC Biologics Business Overview

Table 54. AGC Biologics Antibody Drug CDMO Service Product

Table 55. AGC Biologics Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 56. AGC Biologics Recent Development

Table 57. Axplora Company Details

Table 58. Axplora Business Overview

Table 59. Axplora Antibody Drug CDMO Service Product

Table 60. Axplora Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 61. Axplora Recent Development

Table 62. Batavia Biosciences Company Details

Table 63. Batavia Biosciences Business Overview

Table 64. Batavia Biosciences Antibody Drug CDMO Service Product

Table 65. Batavia Biosciences Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 66. Batavia Biosciences Recent Development

Table 67. ChemExpress Company Details

Table 68. ChemExpress Business Overview

Table 69. ChemExpress Antibody Drug CDMO Service Product

Table 70. ChemExpress Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 71. ChemExpress Recent Development

Table 72. FUJIFILM Company Details

Table 73. FUJIFILM Business Overview

Table 74. FUJIFILM Antibody Drug CDMO Service Product

Table 75. FUJIFILM Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 76. FUJIFILM Recent Development

Table 77. GTP Bioways Company Details

Table 78. GTP Bioways Business Overview

Table 79. GTP Bioways Antibody Drug CDMO Service Product

Table 80. GTP Bioways Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 81. GTP Bioways Recent Development

Table 82. Halix Company Details

Table 83. Halix Business Overview

Table 84. Halix Antibody Drug CDMO Service Product

Table 85. Halix Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 86. Halix Recent Development

Table 87. MYCENAX Company Details

Table 88. MYCENAX Business Overview

Table 89. MYCENAX Antibody Drug CDMO Service Product

Table 90. MYCENAX Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 91. MYCENAX Recent Development

Table 92. WuXi Biologics Company Details

Table 93. WuXi Biologics Business Overview

Table 94. WuXi Biologics Antibody Drug CDMO Service Product

Table 95. WuXi Biologics Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 96. WuXi Biologics Recent Development

Table 97. ProBio Company Details

Table 98. ProBio Business Overview

Table 99. ProBio Antibody Drug CDMO Service Product

Table 100. ProBio Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 101. ProBio Recent Development

Table 102. Samsung Biologics Company Details

Table 103. Samsung Biologics Business Overview

Table 104. Samsung Biologics Antibody Drug CDMO Service Product

Table 105. Samsung Biologics Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 106. Samsung Biologics Recent Development

Table 107. Sigma-Aldrich Company Details

Table 108. Sigma-Aldrich Business Overview

Table 109. Sigma-Aldrich Antibody Drug CDMO Service Product

Table 110. Sigma-Aldrich Revenue in Antibody Drug CDMO Service Business (US$ Million), 2021–2026

Table 111. Sigma-Aldrich Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Antibody Drug CDMO Service Picture

Figure 2. Global Antibody Drug CDMO Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Antibody Drug CDMO Service Market Share by Type: 2025 vs 2032

Figure 4. Customized Service Features

Figure 5. Lab-based Service Features

Figure 6. Others Features

Figure 7. Global Antibody Drug CDMO Service Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Antibody Drug CDMO Service Market Share by Application: 2025 vs 2032

Figure 9. Antibody Drug Conjugates Case Studies

Figure 10. Monoclonal Antibodies Case Studies

Figure 11. Others Case Studies

Figure 12. Antibody Drug CDMO Service Report Years Considered

Figure 13. Global Antibody Drug CDMO Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Antibody Drug CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Antibody Drug CDMO Service Market Share by Region: 2025 vs 2032

Figure 16. Global Antibody Drug CDMO Service Market Share by Players in 2025

Figure 17. Global Antibody Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Antibody Drug CDMO Service Revenue in 2025

Figure 19. North America Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Antibody Drug CDMO Service Market Share by Country (2021–2032)

Figure 21. United States Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Antibody Drug CDMO Service Market Share by Country (2021–2032)

Figure 25. Germany Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Antibody Drug CDMO Service Market Share by Region (2021–2032)

Figure 33. China Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Antibody Drug CDMO Service Market Share by Country (2021–2032)

Figure 41. Mexico Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Antibody Drug CDMO Service Market Share by Country (2021–2032)

Figure 45. Israel Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Antibody Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Abzena Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 49. AGC Biologics Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 50. Axplora Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 51. Batavia Biosciences Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 52. ChemExpress Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 53. FUJIFILM Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 54. GTP Bioways Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 55. Halix Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 56. MYCENAX Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 57. WuXi Biologics Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 58. ProBio Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 59. Samsung Biologics Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 60. Sigma-Aldrich Revenue Growth Rate in Antibody Drug CDMO Service Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Small Molecule Drug CDMO Services Market Research Report 2024

Global Contract Dose Manufacturing Market Insights Forecast to 2030

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Global ADC Drug CDMO Service Market Research Report 2024

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Biologics CDMO Services Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical CDMO Service Market Research Report 2024

Global Pharmaceutical CDMO Market Research Report 2025

Global Chemical CDMO Market Research Report 2024

Global Chemical Drug CDMO Market Research Report 2024

Global Small Molecules CDMO Services Market Research Report 2024

Global Biological Drug CDMO Market Research Report 2024

Global Formulation CDMO Services Market Research Report 2024

Global Biopharmaceutical CDMO Market Research Report 2025

Biologics CDMO Market

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA CDMO Service Market Research Report 2024

Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions